A detailed history of Bml Capital Management, LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Bml Capital Management, LLC holds 2,093,232 shares of CNTB stock, worth $1.99 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares
2,093,232
Previous 2,043,248 2.45%
Holding current value
$1.99 Million
Previous $3.11 Billion 2.95%
% of portfolio
1.77%
Previous 2.22%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$0.99 - $1.6 $49,484 - $79,974
49,984 Added 2.45%
2,093,232 $3.01 Billion
Q2 2024

Aug 07, 2024

SELL
$1.28 - $2.2 $23,155 - $39,798
-18,090 Reduced 0.88%
2,043,248 $3.11 Billion
Q1 2024

Apr 23, 2024

SELL
$1.01 - $1.74 $101 - $174
-100 Reduced -0.0%
2,061,338 $3.59 Billion
Q4 2023

Jan 30, 2024

BUY
$0.7 - $2.06 $1.44 Million - $4.25 Million
2,061,438 New
2,061,438 $2.43 Billion

Others Institutions Holding CNTB

About Connect Biopharma Holdings Ltd


  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $52.3M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Bml Capital Management, LLC Portfolio

Follow Bml Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bml Capital Management, LLC with notifications on news.